Tag: Cystic Fibrosis
Tezacaftor-Ivacaftor, Ivacaftor Alone Effective in CF
And tezacaftor-ivacaftor effective for cystic fibrosis patients homozygous for CFTR Phe508del mutation
Respiratory Microbiome May Influence Inflammation in CF
Less diversity linked to lower IL-8 concentration, neutrophil count in infants with cystic fibrosis
Lumacaftor, Ivacaftor Linked to Improved Lung Function in CF
Findings in patients aged 6 to 11 years with cystic fibrosis homozygous for F508del-CFTR
FDA OKs Kalydeco for Additional Mutations in Cystic Fibrosis
Decision based on results of laboratory testing and previous clinical trials
New Antibiotic Tx Beneficial After Acute Lung Function Decline in CF
Findings among children with cystic fibrosis treated either inpatient, outpatient
Cystic Fibrosis Patients in Canada Live Longer Than Those in U.S.
Canadians with cystic fibrosis live about 10 years longer on average, researchers say
Ultrashort Echo-Time MRI IDs Lung Abnormalities in CF
Strong correlations for CT and UTE MRI scores for pediatric CF patients for bronchiectasis, overall score
Distress Over False-Positive Cystic Fibrosis Screen Not Lasting
Despite immediate distress reported by mothers, psychosocial distress not detected in newborns
Early Antibiotic Treatment Can Be Beneficial in Cystic Fibrosis
Early treatment of Pseudomonas aeruginosa can eradicate bacteria, delay chronic colonization
Guidelines Developed for Preschoolers With Cystic Fibrosis
Recommendations relate to routine surveillance for lung disease, therapeutics, nutritional and GI care
